IMU is starting to get some press in the US with NASDAQ associate RenovoRx (RNXT)
Renovo announced a strategic research collaboration to optimize the delivery of IMU’s oncolytic virus therapy with RenovoRx’s TAMP (Trans-Arterial Micro-Perfusion) therapy platform for the treatment of difficult-to-access tumors.
Also, with a director of NASDAQ Kineta (KA) on our board, we can't help but being noticed in the US space.
RNXT (white plot) / IMU (green) pair comparison.
IMO DYOR
IMU is starting to get some press in the US with NASDAQ...
-
- There are more pages in this discussion • 10,528 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $555.4K | 11.34M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 118 | 16458707 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 1728214 | 12 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |